Choquet H, Yin J, Jacobson AS, Horton BH, Hoffmann TJ, Jorgenson E, Avins AL, Pressman AR, Commun Biol.4(1):864. doi: 10.1038/s42003-021-02356-y., 2021 Jul 22
Associated Topics
Related Publications
Conducting a pilot randomized controlled trial of community-based mindfulness-based stress reduction versus usual care for moderate-to-severe migraine: protocol for the Mindfulness and Migraine Study (M&M).
Pressman A, Law H, Stahl R, Scott A, Jacobson A, Dean L, Sudat S, Obillo A, Avins A.
Trials 2019;20:257.
2019 May 06
Trials 2019;20:257.
2019 May 06
Prevalence of migraine in a diverse community--electronic methods for migraine ascertainment in a large integrated health plan.
Pressman A, Jacobson A, Eguilos R, Gelfand A, Huynh C, Hamilton L, Avins A, Bakshi N, Merikangas K.
Cephalalgia. 36(4):325-34. doi: 10.1177/0333102415590242. Epub 2015 Jun 11.
2016 Apr 01
Cephalalgia. 36(4):325-34. doi: 10.1177/0333102415590242. Epub 2015 Jun 11.
2016 Apr 01
Treatment of refractory chronic demyelinating polyneuropathy with lymphoid irradiation.
Rosenberg NL, Lacy JR, Kennaugh RC, Holers VM, Neville HE, Kotzin BL.
Muscle Nerve. 8(3):223-32.
1985 Mar 01
Muscle Nerve. 8(3):223-32.
1985 Mar 01
Interferon beta-1a in children with multiple sclerosis is well tolerated.
Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J, Miller C, Rensel M, Schwid S, Goodkin D.
Neuropediatrics. 32(4):211-3.
2001 Aug 01
Neuropediatrics. 32(4):211-3.
2001 Aug 01
Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.
Kantor AB, Deng J, Waubant E, Lin H, Becker CH, Lacy JR, Perrone AM, Bennett D, Goelz SE.
J Neuroimmunol. 188(1-2):103-16. Epub 2007 Jul 5.
2007 Aug 01
J Neuroimmunol. 188(1-2):103-16. Epub 2007 Jul 5.
2007 Aug 01